Rilmenidine-induced photosensitivity reaction. 1998

A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
Department of Dermatology and Venereology, Hospital de São João, Porto, Portugal.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D010787 Photosensitivity Disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy. Actinic Reticuloid Syndrome,Dermatitis, Actinic,Photodermatitis,Chronic Actinic Dermatitis,Photosensitization,Actinic Dermatitides,Actinic Dermatitides, Chronic,Actinic Dermatitis,Actinic Dermatitis, Chronic,Actinic Reticuloid Syndromes,Chronic Actinic Dermatitides,Dermatitides, Actinic,Dermatitides, Chronic Actinic,Dermatitis, Chronic Actinic,Disorder, Photosensitivity,Disorders, Photosensitivity,Photodermatitides,Photosensitivity Disorder,Reticuloid Syndrome, Actinic,Reticuloid Syndromes, Actinic,Syndrome, Actinic Reticuloid,Syndromes, Actinic Reticuloid
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077769 Rilmenidine Oxazole derivative that acts as an agonist for ALPHA-2 ADRENERGIC RECEPTORS and IMIDAZOLINE RECEPTORS. It is used in the treatment of HYPERTENSION. 2-(N-(Dicyclopropylmethyl)amino)oxazoline,2-(N-(Dicyclopropylmethyl)amino)oxazoline Phosphate Salt,Hyperium,Oxaminozoline,Rilmenidine Phosphate,S 3341,S-3341,S-3341-3,S3341,S 3341 3,S33413
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
May 1981, Journal of the American Academy of Dermatology,
A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
March 1989, Archives of dermatology,
A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
May 2022, Journal of general and family medicine,
A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
April 1985, The Journal of rheumatology,
A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
January 2013, Indian journal of pharmacology,
A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
September 1975, Archives of dermatology,
A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
October 1995, The Journal of clinical psychiatry,
A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
April 1965, Archives of dermatology,
A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
April 1965, Archives of dermatology,
A V Mota, and C Vasconcelos, and T M Correia, and M A Barros, and J Mesquita-Guimarães
June 2000, Sexually transmitted infections,
Copied contents to your clipboard!